Celldex Therapeutics (CLDX) Prepaid Assets (2010 - 2026)

Celldex Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $7.5 million for Q1 2026.

• In Q1 2026, Prepaid Assets fell 61.17% year-over-year to $7.5 million; the TTM figure through Mar 2026 stood at $7.5 million (down 61.17% YoY), while the FY2025 annual figure was $14.1 million, down 33.53% from the prior year.
• Prepaid Assets was $7.5 million for Q1 2026 at Celldex Therapeutics, down from $14.1 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $22.0 million in Q3 2024 to a low of $5.5 million in Q4 2023.
• Historically, Prepaid Assets has averaged $13.1 million across 5 years, with a median of $11.1 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Prepaid Assets surged 412.78% in 2022, then tumbled 61.17% in 2026.
• A 5-year view of Prepaid Assets shows it stood at $12.4 million in 2022, then slumped by 55.89% to $5.5 million in 2023, then surged by 287.38% to $21.2 million in 2024, then tumbled by 33.53% to $14.1 million in 2025, then sank by 46.48% to $7.5 million in 2026.
• The last three Prepaid Assets figures came in at $7.5 million (Q1 2026), $14.1 million (Q4 2025), and $21.0 million (Q3 2025), per Business Quant data.